Securities code: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) securities abbreviation: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) Announcement No.: 2022011
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)
Announcement of online winning results of public issuance of convertible corporate bonds
Sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918)
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
hot tip
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) (hereinafter referred to as " Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) ," company "or" issuer ") and Zhongtai Securities Co.Ltd(600918) (hereinafter referred to as" sponsor (lead underwriter) "or" Zhongtai Securities Co.Ltd(600918) ") in accordance with the securities law of the people's Republic of China, the measures for the administration of securities issuance by listed companies and the measures for the administration of securities issuance and underwriting (order of the CSRC [No. 144]) Detailed rules for the implementation of convertible corporate bond issuance of Shenzhen Stock Exchange (revised in December 2018) (hereinafter referred to as "detailed rules for the implementation") Shenzhen Stock Exchange Guidelines for business handling of listed companies No. 5 - issuance of convertible corporate bonds to unspecified objects and other relevant provisions publicly issue convertible corporate bonds (hereinafter referred to as "convertible bonds" or "Panlong convertible bonds").
The convertible bonds issued in this public offering shall be placed preferentially to the original shareholders registered by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch (hereinafter referred to as "CSDCC Shenzhen Branch") after the closing of the market on the equity registration date (March 2, 2022, t-1), The balance after the preferential placement of the original shareholders (including the part that the original shareholders give up the preferential placement) is issued to the public investors online through the trading system of Shenzhen Stock Exchange (hereinafter referred to as "Shenzhen Stock Exchange"). Investors are requested to carefully read this announcement and the website of Shenzhen Stock Exchange (www.szse. CN.) The promulgated implementation rules.
Important tips on the issuance process, subscription application, payment and disposal of investors' abandonment are as follows:
1. After winning the subscription of convertible bonds, online investors shall fulfill the obligation of capital settlement in accordance with the announcement of online winning results of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) public offering of convertible corporate bonds (hereinafter referred to as the announcement of online winning results), so as to ensure that their capital account will have sufficient subscription funds on March 7 (T + 2) 2022, The transfer of investors' funds shall comply with the relevant provisions of the securities company where the investors are located. If the investor's subscription fund is insufficient, the insufficient part shall be deemed as giving up the subscription, and the resulting consequences and relevant legal liabilities shall be borne by the investor. According to the relevant regulations of CSDCC Shenzhen Branch, the minimum unit to give up subscription is 1 piece. The part that online investors give up subscription shall be underwritten by the sponsor (lead underwriter).
2. When the total number of convertible bonds subscribed by the original shareholders and the number of convertible bonds subscribed by online investors is less than 70% of the number of this issue; Or when the total number of convertible bonds subscribed by the original shareholders and the number of convertible bonds subscribed by online investors is less than 70% of the number of this issuance, the issuer and the recommendation institution (lead underwriter) will negotiate whether to take measures to suspend the issuance and report to the China Securities Regulatory Commission and Shenzhen Stock Exchange in a timely manner; If the issuance is suspended, announce the reasons for the suspension and choose the opportunity to restart the issuance.
The part of the subscription amount of this offering less than 276 million yuan shall be underwritten by the sponsor (lead underwriter). The underwriting base of this issuance is 276 million yuan. The recommendation institution (lead underwriter) shall determine the final placement result and underwriting amount according to the online capital arrival. In principle, the underwriting proportion shall not exceed 30% of the total amount of this issuance, that is, in principle, the maximum underwriting amount is 82.8 million yuan. When the actual underwriting ratio exceeds 30% of the total amount of this issuance, the recommendation institution (lead underwriter) will start the internal underwriting risk assessment procedure, continue to perform the issuance procedure or take measures to suspend the issuance after reaching an agreement with the issuer, and report to the China Securities Regulatory Commission and Shenzhen Stock exchange in a timely manner.
3. If an online investor has won the lottery for 3 times but failed to pay in full within 12 consecutive months, it shall not participate in the subscription of online new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant's latest declaration of abandonment of subscription.
The situation of abandoning subscription shall be judged by investors. The number of times of abandonment of subscription shall be calculated according to the cumulative number of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds actually abandoned by investors; If an investor holds multiple securities accounts and abandons subscription in any one of the securities accounts, the number of times of abandonment shall be calculated cumulatively. The situations of abandonment of subscription occurred in disqualification and cancellation of securities accounts are also included in the statistics.
For the special account for directional asset management and enterprise annuity account of customers of securities companies, if the "account holder's name" and "valid identity document number" in the registration data of securities accounts are the same, statistics shall be made according to different investors.
According to the announcement of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) public issuance of convertible corporate bonds, the issuer and the sponsor (lead underwriter) of this issuance presided over the lottery ceremony of online issuance of Panlong convertible bonds on March 4, 2022 (T + 1). The lottery ceremony was conducted under the supervision of representatives of relevant units in accordance with the principles of openness, fairness and impartiality. The results of the lottery were notarized by Luohu Notary Office of Shenzhen City, Guangdong Province.
The winning results are announced as follows:
Last digit winning lot number
Last six digits 588446088446338446838446
Last seven digits 73560831356083335608353560839356083
Last eight digits: 089921205899212064663220
268548943068548943468548943668548943，
Last nine digits
868548943350566970850566970
4498194279049819427924981942796498194279，
Last ten digits
eight billion four hundred and ninety-eight million one hundred and ninety-four thousand two hundred and seventy-nine
If the mantissa of the subscription allotment number held by the investors participating in the online subscription of Panlong convertible bonds is the same as the above number, it is the winning number. There are 54318 winning numbers in total, and each winning number can only subscribe for one hand (10 pieces, 1000 yuan) of Panlong convertible bonds.
It is hereby announced.
Issuer: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918) March 7, 2022
Issuer: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) March 7, 2022 (there is no text on this page, which is the seal page of the announcement of online winning results of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) public offering of convertible corporate bonds)
Sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918) March 7, 2022
